IMVT vs REGN: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Regeneron Pharmaceuticals Inc in 2026
IMVT
Immunovant Inc
$26.55
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | IMVT | REGN | Winner |
|---|---|---|---|
| Market Cap | $5.11B | $78.92B | REGN |
| P/E Ratio | N/A | 17.99 | REGN |
| EPS (TTM) | $N/A | $41.50 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze IMVT
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or REGN a better investment?
Comparing IMVT and REGN: Immunovant Inc has a market cap of $5.11B while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and REGN?
IMVT (Immunovant Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for IMVT.
Which company is more profitable: IMVT or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for IMVT.
Which is the larger company: IMVT or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $5.11B for IMVT.
Should I buy IMVT or REGN in 2026?
Both IMVT and REGN have investment merit. IMVT trades at $26.55 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and REGN stock?
Key differences: Market Cap ($5.11B vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).